SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001161697-17-000249
Filing Date
2017-05-19
Accepted
2017-05-19 17:26:43
Documents
42
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q QUARTERLY REPORT FOR 03-31-2017 form_10-q.htm 10-Q 254039
2 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION ex_31-1.htm EX-31 5969
3 SECTION 1350 CERTIFICATION ex_32-1.htm EX-32 3618
4 GRAPHIC angiosoma_logo.jpg GRAPHIC 29521
  Complete submission text file 0001161697-17-000249.txt   1703729

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE soan-20170331.xml EX-101.INS 250044
6 XBRL SCHEMA FILE soan-20170331.xsd EX-101.SCH 22672
7 XBRL CALCULATION FILE soan-20170331_cal.xml EX-101.CAL 29824
8 XBRL DEFINITION FILE soan-20170331_def.xml EX-101.DEF 75840
9 XBRL LABEL FILE soan-20170331_lab.xml EX-101.LAB 163075
10 XBRL PRESENTATION FILE soan-20170331_pre.xml EX-101.PRE 130801
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Filer) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-55072 | Film No.: 17858969
SIC: 1311 Crude Petroleum & Natural Gas